Growth Metrics

Novavax (NVAX) Other Non-Current Assets: 2009-2025

Historic Other Non-Current Assets for Novavax (NVAX) over the last 16 years, with Sep 2025 value amounting to $107.7 million.

  • Novavax's Other Non-Current Assets rose 252.45% to $107.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $107.7 million, marking a year-over-year increase of 252.45%. This contributed to the annual value of $24.0 million for FY2024, which is 31.74% down from last year.
  • Per Novavax's latest filing, its Other Non-Current Assets stood at $107.7 million for Q3 2025, which was up 403.29% from $21.4 million recorded in Q2 2025.
  • Novavax's 5-year Other Non-Current Assets high stood at $107.7 million for Q3 2025, and its period low was $17.4 million during Q3 2022.
  • Its 3-year average for Other Non-Current Assets is $36.8 million, with a median of $31.0 million in 2024.
  • Per our database at Business Quant, Novavax's Other Non-Current Assets surged by 384.51% in 2021 and then plummeted by 54.60% in 2022.
  • Quarterly analysis of 5 years shows Novavax's Other Non-Current Assets stood at $24.3 million in 2021, then climbed by 17.20% to $28.5 million in 2022, then rose by 23.50% to $35.2 million in 2023, then slumped by 31.74% to $24.0 million in 2024, then skyrocketed by 252.45% to $107.7 million in 2025.
  • Its Other Non-Current Assets was $107.7 million in Q3 2025, compared to $21.4 million in Q2 2025 and $21.9 million in Q1 2025.